In 2019 the research group behind R&D company Neores won both the Athena prize and the Medtech4Health Innovation Award for their rPAP breathing aid designed for babies born too early. Now Neores has announced it is taking the next step in building its business by joining Umeå Biotech Incubator (UBI).
The life science company InfiCure Bio has started the new year in the best way by signing an agreement with a new client in the US. "The company's goal for 2023 is to increase the visibility of our NIF model by continuing our strategy to promote the model on multiple markets”
Umeå Biotech Incubator (UBI) will represent Umeå’s life science industry as part of the annual ‘Västerbotten på Grand Hôtel i Stockholm’ event being held in January. “We want to contribute to Umeå’s growth as a life science city by connecting the life science industry with local, regional, and national decision-makers”, says UBI’s CEO Jennie Ekbeck.
Umeå-based life science company Diamyd Medical continues to recruit specialists for its new manufacturing unit.
“For a scientist it is a fun and challenging place to work, where you really feel your knowledge makes a big difference and means something”, says Maria Åhman, Quality Assurance Manager at Diamyd Medical.
The company announced it was moving the production of GAD65 protein, the acti
Umeå based Inficure Bio and InnoSer have teamed up to offer Inficure Bio’s spontaneous liver inflammation & fibrosis mouse model (NIF mouse) as part of InnoSer’s expanding cardio-metabolic services portfolio. This is the third signed international agreement in a month for InfiCure Bio.
"This expansion will enable us to increase productivity and deliver more products to the market”, says Niklas Norgren, VP and Managing Director.
The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies. "This is yet more proof of the need for and the potential of our model" says Sofia Mayans, CEO of InciCure Bio.
The former CEO of chemical industry giant Perstorp Martin Lundin has been appointed Chairman of the Board for Umeå-based Spinchem AB. “Spinchem combines fascinating cutting-edge technology with talented employees while operating in an exciting market”, says Martin Lundin.
Umeå Biotech Incubator (UBI) is ranked as one of the best Life science incubators in Europa. Now UBI launches an international incubator program. “If you strive to be one of the world's best incubators you must have the whole world as your marketplace”, says Jennie Ekbeck, CEO of UBI.
The Umeå company Xerum has received a new national assignment to measure the presence of antibodies against SARS-CoV-2, the virus that causes covid-19 in Sweden. Xerum has performed and analyzed around 10 000 tests during the pandemic.
Mucocort AB is a Swedish company that has developed a unique self-absorbing pain relief patch for people suffering from recurrent mouth ulcers - aphthous stomatitis. The company has now signed a production agreement with medical technology company Aurena Laboratories AB, which also becomes a stakeholder in Mucocort.
The Umeå-based biopharmaceutical company Omnio AB, focusing on wound healing, has received a capital injection of 1.5 million euros from its shareholders, which will be used for ongoing development work and to begin creating a blueprint for manufacturing.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden